SCHEMBL25840797

SCHEMBL25840797

Cc1ccc(NC(=O)NCCP(=O)(O)O)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.57
CNR1 P21554 3/20 0.55
ALDH1A1 P00352 2/20 0.55
CASR P41180 1/20 0.55
CYP1A2 P05177 1/20 0.55
CYP3A4 P08684 1/20 0.55
CYP2C9 P11712 1/20 0.55
CYP2C19 P33261 1/20 0.55
RAB9A P51151 5/20 0.50
SMN1; SMN2 Q16637 4/20 0.49
TP53 P04637 2/20 0.49
MEN1 O00255 1/20 0.49
HPGD P15428 1/20 0.49
KMT2A Q03164 1/20 0.49
POLB P06746 2/20 0.49
SLC6A3 Q01959 1/20 0.48
CA12 O43570 1/20 0.48
CA1 P00915 1/20 0.48
CA2 P00918 1/20 0.48
CA4 P22748 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25840803 0.91 ALDH1A1 (0.59) NPC1CNR1ALDH1A1CASRCYP1A2
SCHEMBL12018601 0.87 NPC1 (0.57) NPC1CNR1ALDH1A1CASRCYP1A2
SCHEMBL25840785 0.83 NPC1 (0.60) NPC1CNR1ALDH1A1CASRCYP1A2
SCHEMBL25840801 0.83 SMN1; SMN2 (0.54) NPC1ALDH1A1CYP1A2CYP3A4CYP2C9
SCHEMBL23328445 0.80 MEN1 (0.67) NPC1CNR1RAB9AMEN1KMT2A
SCHEMBL10192175 0.80 MEN1 (0.66) NPC1CNR1ALDH1A1CASRCYP1A2
SCHEMBL12994639 0.80 NPC1 (0.64) NPC1CNR1ALDH1A1CASRCYP1A2
SCHEMBL23457297 0.79 NPC1 (0.58) NPC1CNR1ALDH1A1CASRCYP1A2
SCHEMBL10192079 0.78 CNR1 (0.63) NPC1CNR1ALDH1A1CASRCYP1A2
SCHEMBL27922916 0.78 CNR1 (0.73) NPC1CNR1ALDH1A1CASRCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11701333-B2 Antibacterial compounds Kent Innovation & Enterprise (GB) 2023-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11701333-B2 Antibacterial compounds ARF1, ARL1, TLR1 NPC1 407/4885CNR1 902/4885ALDH1A1 465/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.